Petros Pharmaceuticals, Inc. Debt Instrument, Periodic Payment
Petros Pharmaceuticals, Inc. (PTPI) reported Debt Instrument, Periodic Payment of $9.66 million for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentPeriodicPayment · last filed 2022-11-15
- Petros Pharmaceuticals, Inc. debt instrument, periodic payment for the quarter ending 2022-09-30 was -$361.95K.
| Period end | Debt Instrument, Periodic Payment 3 month | Debt Instrument, Periodic Payment 6 month | Debt Instrument, Periodic Payment 9 month |
|---|---|---|---|
| 2022-09-30 | -$361.95K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | $9.66M 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $10.02M 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |